- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Upper Tract Urothelial Carcinoma
Total 13390 results
-
Peking University Cancer Hospital & InstituteUnknown
-
Genentech, Inc.TerminatedUrothelial CarcinomaKorea, Republic of, United States, Canada, United Kingdom, Belgium
-
Hoosier Cancer Research NetworkNovartis PharmaceuticalsWithdrawnUrothelial Carcinoma
-
Asan Medical CenterCompletedUrothelial CarcinomaKorea, Republic of
-
National Taiwan University HospitalUnknown
-
National Cancer Institute (NCI)RecruitingStage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Bladder Adenocarcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Bladder... and other conditionsUnited States, Puerto Rico
-
Pacific Edge LimitedWithdrawnUpper Tract Urinary Carcinoma
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingAdrenocortical Carcinoma | Penile Cancer | Genitourinary Cancer | Non-urothelial Bladder | Non-urothelial Upper Tract | Non-adenocarcinoma Prostate Cancer | Refractory Germ-cell | High Grade Neuroendocrine Carcinoma/Small Cell CarcinomaUnited States
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Lawrence FongCellSight Technologies, Inc.Terminated
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineTerminated
-
University of MichiganPfizerTerminatedBladder Cancer | Urothelial CarcinomaUnited States
-
National Taiwan University HospitalUnknown
-
Mansoura UniversityUnknownCystoscopy | Bladder Urothelial Carcinoma | Bladder Neoplasm | TURBTEgypt
-
National Cancer Institute (NCI)Not yet recruitingNon-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
SCRI Development Innovations, LLCCelgeneTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Bladder Carcinoma | Recurrent Prostate Carcinoma | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Metastatic Renal Pelvis and Ureter Urothelial Carcinoma | Localized... and other conditionsUnited States
-
Wuhan Union Hospital, ChinaNot yet recruitingUrothelial Carcinoma
-
Yung NAQueen Mary Hospital, Hong Kong; Pamela Youde Nethersole Eastern HospitalRecruitingMuscle-Invasive Bladder Carcinoma | Muscle Invasive Bladder Urothelial CarcinomaHong Kong
-
University of Michigan Rogel Cancer CenterNot yet recruitingUrothelial CarcinomaUnited States
-
Peking University First HospitalRecruiting
-
Peking University Cancer Hospital & InstituteRecruiting
-
Abbisko Therapeutics Co, LtdRecruitingUrothelial CarcinomaChina
-
BeiGeneRecruiting
-
Lee's Pharmaceutical LimitedRecruiting
-
Weill Medical College of Cornell UniversityNeoTX Therapeutics Ltd.WithdrawnUrothelial CarcinomaUnited States
-
University of FloridaCompletedUrothelial CarcinomaUnited States
-
The Netherlands Cancer InstituteAstraZenecaActive, not recruitingUrothelial CarcinomaNetherlands
-
Case Comprehensive Cancer CenterCompletedUrothelial CarcinomaUnited States
-
4D pharma plcWithdrawnUrothelial CarcinomaUnited States
-
Arjun Balar, MDHoosier Cancer Research Network; Roche-GenentechTerminatedUrothelial CarcinomaUnited States
-
BayerCompletedCarcinoma, Transitional CellUnited States, Spain, Hungary, China, Belgium, Korea, Republic of, Taiwan, Australia, Singapore, Canada, Japan, Sweden, Russian Federation, Germany, Italy, Israel, Ireland, France, Austria, Denmark, Portugal, Switzerland, Czechia, Slo... and more
-
Sohag UniversityCompleted
-
University of Turin, ItalyTesaro, Inc.Completed
-
Samsung Medical CenterActive, not recruitingUrothelial CarcinomaKorea, Republic of
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedUrothelial CarcinomaFrance
-
Hoffmann-La RocheTerminated
-
Mirati Therapeutics Inc.CompletedUrothelial CarcinomaUnited States
-
Henan Cancer HospitalRecruitingIntraoperative Complications | Perfusion; Complications | High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
Shandong TheraWisdom Biopharma Co., Ltd.RecruitingAdvanced Melanoma | Advanced Urothelial CarcinomaChina
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Locally Advanced Urothelial CarcinomaUnited States, Canada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)SuspendedStage II Bladder Cancer AJCC v8 | Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall | Infiltrating Renal Pelvis and Ureter Urothelial CarcinomaUnited States
-
IRCCS San RaffaeleRecruitingBladder Cancer | Bladder Disease | Bladder Cancer Recurrent | Bladder Urothelial Carcinoma | Non Muscle Invasive Bladder Cancer | Bladder Neoplasm | Non-Muscle Invasive Bladder Urothelial Carcinoma | Non-Muscle Invasive Bladder Neoplasms | Bladder Cancer Stage I, With Cancer in Situ | Bladder Urothelial... and other conditionsItaly
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Bladder Urothelial Carcinoma | Bladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Superficial Bladder Urothelial CarcinomaUnited States
-
UroGen Pharma Ltd.RecruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Urothelial Carcinoma Bladder | NMIBC | Urothelial Carcinoma Recurrent | Carcinoma in Situ of BladderUnited States, Italy, Spain
-
National Cancer Institute (NCI)WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8Canada
-
University of FloridaRecruitingUrothelial Carcinoma BladderUnited States
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
National Cancer Institute (NCI)RecruitingRenal Pelvis and Ureter Urothelial CarcinomaUnited States